Anti-inflammatory agents in the management of alimentary mucositis
Alimentary mucositis is a significant complication of cancer therapy, with important clinical and economic implications.
Materials and methods
In June 2005, the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society for Oral Oncology conducted an evidence-based review of the literature on alimentary mucositis. The goal of this literature review was to update previously published guidelines for the management of mucositis.
This article reports the findings of the subgroup charged with reviewing the literature related to anti-inflammatory interventions. Considerable preclinical and clinical evidence suggests that the use of anti-inflammatory agents may be a promising approach to reduce the severity of mucositis. However, there was not enough evidence to support any new guidelines advocating the use of any specific anti-inflammatory intervention.
Thus, there is a need for well-designed clinical trials evaluating the use of anti-inflammatory agents in the management of mucositis.
KeywordsAllopurinol Misoprostol Mesalazine Oral Mucositis Neck Cancer Patient
The authors thank Mr. Ronald D. Hutchins, University of Texas MD Anderson Cancer Center, for conducting the literature search.
- 2.Baughan CA, Canney PA, Buchanan RB et al (1993) A randomized trial to assess the efficacy of 5-aminosalicylic acid for the prevention of radiation enteritis. Clin Oncol (R Coll Radiol) 5:19–24Google Scholar
- 15.Johnson DJ, Scott CB, Marks JE et al (2002) Assessment of quality of life and oral function of patients participating in a phase II study of radioprotection of oral and pharyngeal mucosa by the prostaglandin E(1) analog misoprostol (RTOG 96-07). Int J Radiat Oncol Biol Phys 54:1455–1459CrossRefPubMedGoogle Scholar
- 16.Khan AM, Birk JW, Anderson JC et al (2000) A prospective randomized placebo-controlled double-blinded pilot study of misoprostol rectal suppositories in the prevention of acute and chronic radiation proctitis symptoms in prostate cancer patients. Am J Gastroenterol 95:1961–1966CrossRefPubMedGoogle Scholar
- 34.RxKinetix, Inc., Louisville, CO (2005) RxKinetix sucessfully concludes its phase 2 trial in oral mucositis. http://www.rxkinetix.com. Cited 18 Oct 2005
- 37.Somerfield MR, Padberg JR, Pfister DG et al (2000) ASCO clinical practice guidelines: process, progress, pitfalls, and prospects. Classic Papers and Current Comments 4:881–886Google Scholar
- 40.Sonis ST, O’Donnell KE, Rishi P et al (2003) Inhibition of ceramide synthase, but not sphingomyelinase, attenuates radiation-induced mucositis in hamsters. Proc Am Soc Clin Oncol 22:747 (Abstract 3005)Google Scholar
- 51.Xun CQ, Thompson JS, Jennings CD et al (1994) Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2- incompatible transplanted SCID mice. Blood 83:2360–2367PubMedGoogle Scholar
- 52.Yeoh AS, Bowen JM, Gibson RJ et al (2005) Nuclear factor kappaB (NFkappaB) and cyclooxygenase-2 (Cox-2) expression in the irradiated colorectum is associated with subsequent histopathological changes. Int J Radiat Oncol Biol PhysGoogle Scholar